Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowBone Marrow TransplantationLeukapheresisBone Marrow CellsGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsStem CellsTransplantation, HomologousBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft vs Host DiseaseMelphalanCyclophosphamideCombined Modality TherapyBone and BonesGraft SurvivalMultiple MyelomaStem Cell TransplantationBlood CellsBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountHematopoiesisCord Blood Stem Cell TransplantationTreatment OutcomeLymphoma, Non-HodgkinBone Marrow PurgingTissue DonorsEtoposideAntineoplastic Agents, AlkylatingMyeloablative AgonistsTransplantation ChimeraThiotepaRecurrenceWhole-Body IrradiationRemission InductionLeukemiaHistocompatibilityFlow CytometryColony-Forming Units AssayCell DifferentiationCell SeparationPlatelet CountHistocompatibility TestingTime FactorsIfosfamideCells, CulturedBlood DonorsImmunophenotypingAnemia, AplasticEmbryonic Stem CellsCytarabineDisease-Free SurvivalLeukocytes, MononuclearLeukemia, Myeloid, AcuteNeoplasmsRecombinant ProteinsLeukocyte CountInfectionAdult Stem CellsTransplantation, IsogeneicLymphomaBone RemodelingVidarabineHodgkin DiseasePOEMS SyndromeImmunomagnetic SeparationAntigens, CDVincristineRetrospective StudiesSalvage TherapySurvival RateImmunosuppressive AgentsBone Marrow ExaminationT-LymphocytesStem Cell FactorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisBone Marrow NeoplasmsCarmustineGranulocytesMyelodysplastic SyndromesHematologic DiseasesLymphocyte DepletionProchlorperazinePlatelet TransfusionGranulocyte-Macrophage Colony-Stimulating FactorPluripotent Stem CellsDoxorubicinCell CountBone NeoplasmsLeukocyte TransfusionNeoplasm, Residual